Brohl, A. S., Burgess, M. A., In, G. K., Khaddour, K., O'Neill, P. M., Reddy, S. A., Whitman, E. D., Bianco, J. A. (2025). Multicenter, randomized, double-blinded, placebo-controlled trial of IFx-Hu2.0 (IFx) as adjunctive therapy with pembrolizumab (pembro) in checkpoint inhibitor (CPI)-naïve patients with advanced or metastatic Merkel cell carcinoma (MCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps9603